• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

ENOXAPARIN Drug Record

  • Summary
  • Interactions
  • Claims
  • ENOXAPARIN chembl:CHEMBL1201685

    Alternate Names:

    ENOXAPARIN

    Drug Info:

    Year of Approval 1993
    Drug Class anticoagulants
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications anticoagulant
    (1 More Sources)

    Publications:

    Arbit E et al., 2006, Oral heparin: status review., Thromb J
    Bisio et al., 2009, Structural features of low-molecular-weight heparins affecting their affinity to antithrombin., Thromb. Haemost.
    Peng et al., 2005, [Effects of thrombolysis and anticoagulation on the functions of vascular endothelial cells and coagulation and fibrinolysis in patients with pulmonary thromboembolism]., Zhonghua Jie He He Hu Xi Za Zhi
    Lee et al., 2007, Enoxaparin in acute coronary syndromes., Expert Rev Cardiovasc Ther
    Hong et al., 2003, Glycoprotein IIb/IIIa receptor antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-[[2-([4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl]amino)acetyl]amino]propanoic acid dihydrochloride (CRL42796), in combination with aspirin and/or enoxaparin, prevents coronary artery rethrombosis after successful thrombolytic treatment by recombinant tissue plasminogen activator., J. Pharmacol. Exp. Ther.
  • ENOXAPARIN   SERPINC1

    Interaction Score: 5.38

    Interaction Types & Directionality:
    activator (activating)
    potentiator

    Interaction Info:

    PMIDs:
    16686945 19888521 16207425 17489664


    Sources:
    TEND TTD

  • ENOXAPARIN   ITGA2B

    Interaction Score: 4.58

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    12734394


    Sources:
    NCI

  • ENOXAPARIN   F2

    Interaction Score: 0.71

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Lovenox
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TEND: ENOXAPARIN

    • Version: 01-August-2011

    Alternate Names:
    ENOXAPARIN Primary Drug Name

    Drug Info:
    Drug Class anticoagulants
    Year of Approval 1993

    Publications:

  • TdgClinicalTrial: ENOXAPARIN

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications anticoagulant
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

  • NCI: ENOXAPARIN

    • Version: 14-September-2017

    Alternate Names:
    C1452 NCI drug code

    Drug Info:

    Publications:
    Hong et al., 2003, Glycoprotein IIb/IIIa receptor antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-[[2-([4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl]amino)acetyl]amino]propanoic acid dihydrochloride (CRL42796), in combination with aspirin and/or enoxaparin, prevents coronary artery rethrombosis after successful thrombolytic treatment by recombinant tissue plasminogen activator., J. Pharmacol. Exp. Ther.

  • TTD: Enoxaparin

    • Version: 2020.06.01

    Alternate Names:
    D0MX5S TTD Drug ID

    Drug Info:

    Publications:
    Arbit E et al., 2006, Oral heparin: status review., Thromb J

  • ChemblDrugs: chembl:CHEMBL1201685

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21